Preoperative bevacizumab combined with letrozole and chemotherapy in locally advanced ER- and/or PgR-positive breast cancer: clinical and biological activity

The antiangiogenic agent bevacizumab showed synergistic effects when combined with chemotherapy in advanced breast cancer. We presently investigated the activity of bevacizumab in combination with chemotherapy, including capecitabine and vinorelbine, and endocrine therapy, including letrozole (+trip...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Principais autores: Torrisi, R, Bagnardi, V, Cardillo, A, Bertolini, F, Scarano, E, Orlando, L, Mancuso, P, Luini, A, Calleri, A, Viale, G, Goldhirsch, A, Colleoni, M
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2008
Assuntos:
Clinical Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2584958/
https://ncbi.nlm.nih.gov/pubmed/18941458
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6604741
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados